In this episode, we explore the addiction treatment continuum to help you determine when to prioritize pharmacotherapy versus psychotherapy for opioid, stimulant, and alcohol use disorders. We provide a deep dive into Brixadi, a new long-acting injectable buprenorphine, comparing its weekly and monthly dosing options to Sublocade and discussing its potential role in rapid induction protocols34. Expert insights on Motivational Interviewing and 12-Step Facilitation offer practical communication strategies to resolve patient ambivalence and improve engagement with recovery communities56. You will also learn about emerging evidence for microinduction strategies in hospitalized patients and the safety of initiating injectables in the emergency department47. These clinical pearls will equip you with the latest evidence-based tools to tailor treatment plan ...